Novo Nordisk stock (NVO) plunged approximately 15% after the Danish pharmaceutical giant posted better-than-expected 2025 results but delivered a weak 2026 outlook. The company reported full-year 2025... ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the blockbuster weight-loss market. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Yes □ No 区 If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g-32(b):82- FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 4 February 2026 NOVO NORDISK A/S (Exact name of Registrant as specified in its charter) Novo Allé DK-2880 Bagsværd Denmark (Address of principal executive offices) Indicate by check mark whether the ...

诺和诺德董事会已决定启动一项高达150亿丹麦克朗的新股票回购计划。 来源：滚动播报 ...

Danish drug maker Novo Nordisk said on Wednesday it had appointed Jamey Millar head of its U.S. business, and Hong Chow head of product and portfolio strategy. ...

本文源自：金融界AI电报 诺和诺德(NVO.N)股价跌幅持续扩大，现跌超13%。 ...

The Danish drugmaker said adjusted sales should decline between 5% and 13% at constant exchange rates in 2026, a reversal from last year, when sales grew 10%. ...

本文源自：金融界AI电报 诺和诺德预计本财年净利润为1024亿丹麦克朗。 ...

本文源自：金融界AI电报 诺和诺德预计本财年销售额为3090.64亿丹麦克朗，低于市场预估的3430.17亿丹麦克朗；预计本财年营 业利润为1276.58亿丹麦克朗。 ...